Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection
NCT04409184 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2020-08-18
Summary
The study was not opened.
Conditions
- COVID
- Sars-CoV2
Sponsors & Collaborators
-
Versiti
collaborator OTHER -
Medical College of Wisconsin
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-14
- Primary Completion
- 2020-08-14
- Completion
- 2020-08-14
More Related Trials
-
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients
NCT04421404 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients
NCT04354831 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.
NCT04397757 ·Status: COMPLETED ·Phase: PHASE1
-
Collection of Anti-SARS-CoV-2 Immune Plasma
NCT04344977 ·Status: COMPLETED
-
Convalescent Plasma for Patients With COVID-19
NCT04385199 ·Status: COMPLETED ·Phase: PHASE2
-
Convalescent Plasma in Outpatients With COVID-19
NCT04355767 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients
NCT04474340 ·Status: UNKNOWN ·Phase: PHASE1
-
Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19
NCT04393727 ·Status: TERMINATED ·Phase: PHASE2
-
Convalescent Plasma in the Treatment of COVID 19
NCT04343261 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Infection in Patients Receiving Anti-CD20 Therapy
NCT04884477 ·Status: COMPLETED
-
Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)
NCT04554992 ·Status: COMPLETED ·Phase: PHASE1
-
Convalescent Plasma vs. Standard Plasma for COVID-19
NCT04344535 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Convalescent Plasma for Early Treatment of COVID-19
NCT04390503 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19
NCT04433910 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients
NCT04471051 ·Status: COMPLETED
-
Convalescent Plasma Therapy - Zurich Protocol
NCT04869072 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy
NCT04361253 ·Status: TERMINATED ·Phase: PHASE3
-
Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)
NCT04342182 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
NCT04373460 ·Status: COMPLETED ·Phase: PHASE2
-
Convalescent Plasma for the Treatment of COVID-19
NCT04389710 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection
NCT06084351 ·Status: WITHDRAWN ·Phase: PHASE3
-
Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection
NCT04408209 ·Status: COMPLETED ·Phase: NA
-
Convalescent Plasma as a Possible Treatment for COVID-19
NCT04442191 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19
NCT04438057 ·Status: COMPLETED ·Phase: PHASE2
-
CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients
NCT04364737 ·Status: COMPLETED ·Phase: PHASE2